Publication | Closed Access

Aldose reductase inhibition properties of novel thiazolidin-2,4-diones: In vitro and in silico approach for the treatment of diabetes-related complications

Metabolic SyndromeAldo-keto ReductaseBiochemistrySilico ApproachMedicineDiabetesDiabetes MellitusDiabetes-related ComplicationsPharmacologyDrug DiscoveryNovel Thiazolidin-2,4-diones